13601_2019_293_MOESM1_ESM.docx (23.25 kB)
MOESM1 of Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis
journal contribution
posted on 2019-10-09, 07:01 authored by Joaquim Mullol, Iñaki Izquierdo, Kimihiro Okubo, Giorgio Canonica, Jean Bousquet, Antonio ValeroAdditional file 1: Table S1. Characteristics of rupatadine clinical studies included in the pooled analysis. Table S2. Effects of rupatadine treatment on total nasal symptom (T4NSS), ocular symptom (T2OSS), and total symptom (T6SS) scores.